Mensahmedical.com

¨  Incidence: 1% of World Population ¨  Inherited Predisposition: > 50% Concordance in ¨  Typical Onset Between 15-26 yrs ¨  Higher incidence in northern Scandinavia and ¨  Ancient times to year 1800: Belief in possession by evil spirits…. treatments included exorcism and trepanation (drilling holes in skull). ¨  1800: Recognition of SZ as mental disease. ¨  1905: Belief SZ caused by negative life experiences; ¨  1950: Use of antipsychotic medications. ¨  1975: Advent of biological psychiatry…. focus on ¨  Failure to recognize that schizophrenia is an “umbrella term” given to several different mental disorders. ¨  The schizophrenia phenotypes likely have different causes, and involve differences in brain chemistry. ¨  Optimal treatment requires a therapy tailored to Identification of Schizophrenia Phenotypes ¨  Chemical studies of 25,000 schizophrenics by Pfeiffer (Princeton, NJ) and Walsh ( Naperville, IL). ¨  > 1 million chemical assays of blood & urine. ¨  Very high incidence of chemical abnormalities, ¨  About 50-150 symptoms, traits, and physical characteristics were recorded for each patient and research subject, ¨  The symptoms & traits associated with specific ¨  Biochemical classifications of schizophrenia were ¨  27% - Pyrrole disorder (severe oxidative stress) ¨  Elevated SAMe/SAH ratio in blood ¨  Depressed whole-blood histamine ¨  Overmethylation dominant imbalance ¨  High norepinephrine & dopamine
Note: The most common psychiatric diagnosis is
Paranoid Schizophrenia

¨  Intolerance to SSRI Antidepressants ¨  Metallothionein Promotion Therapy - SSRI Antidepressants must be avoided - Antihistamines must be avoided - Klonapin may assist in reducing anxiety. Symptoms & Traits
¨  Severe Deficiencies of B-6, Zinc ¨  Benzodiazapines (especially Klonapin) Medication support may become unnecessary after ¨  Incomplete Breakdown of Gluten Proteins in the ¨  Short Peptides with Opioid Properties
Treatment: Dietary Avoidance of Wheat, Oats,
Initiation of Nutrient Therapy: Meds continued at full dosage for several months, unless sedation becomes excessive. Months 4-12: After significant improvement, med dosages may be cautiously reduced to tolerance; Long-Term Care: Low-dose medication support usually ¨  Overmethylation: Major Improvement ¨  Pyrrole Disorder: Moderate Improvement ¨  Undermethylation: Slight Improvement ¨  Oxidative stresses gradually increase until GSH and MT proteins are overwhelmed, resulting in sudden brain inflammation, alteration of NT levels, and disruption of the blood brain barrier. ¨  As in Wilson’s Disease, sudden onset of a mental illness ¨  All major phenotypes of schizophrenia involve severe ¨  Oxidative overload depletes GSH and reduces ¨  Clear evidence of brain cell loss in schizophrenia: Archives
of General Psychiatry, January 2006.
¨  Most antipsychotic medications have antioxidant ¨  Abnormal methylation and severe oxidative stress ¨  Greater than 95% of schizophrenics exhibit abnormal methylation or oxidative overload. ¨  This could explain failure of schizophrenia to obey ¨  85% report that “life is better” after nutrient ¨  75% report ability to reduce medication, ¨  Highest efficacy for overmethylation and pyrrole ¨  Many cases of complete recovery.

Source: http://www.mensahmedical.com/images/Schizophrenia-PP_1.pdf

Microsoft word - gravitas half enrolled release final.doc

Accumetrics, Inc. Announces GRAVITAS Trial 50 Percent Enrolled June 30, 2009, San Diego, Calif. -- Accumetrics, Inc. announces that it has reached the halfway mark (1,600 patients) in the enrollment of its landmark clinical trial, GRAVITAS ( G auging R esponsiveness with A V erifyNow® Assay I mpact on T hrombosis A nd S afety). The trial is specifically designed to demonstrate the

Genmapp

TCA Cycle pyruvate pyruvate carboxylase 1 pyruvate carboxylase 2 cytoplasmic malate dehydrogenase mitochondrial malate dehydrogenase phosphate acetyl-CoA malate dehydrogenase oxaloacetic acid citrate synthase 3 citrate synthase 1 citrate synthase 2 Gene Database Coenzyme A Sc-Std_20070817.gdb Expression Dataset Name: all Color Sets: fumar

Copyright © 2010 Medicament Inoculation Pdf